[Effect of spironolactone in experimental myocardial necrosis].
D000307:Adrenal Gland Diseases / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology; D000311:Adrenal Glands / Q000473:pathology; D000818:Animals; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D006965:Hyperplasia / Q000139:chemically induced; D008297:Male; D009206:Myocardium / Q000032:analysis / Q000473:pathology; D009336:Necrosis / Q000139:chemically induced / Q000188:drug therapy; D011188:Potassium / Q000032:analysis / Q000097:blood; D051381:Rats; D013148:Spironolactone / Q000627:therapeutic use*
D013148:Spironolactone; D011188:Potassium
Untersuchung über die Wirkung von Spironolakton auf die experimentelle Myokardnekrose.